2020
DOI: 10.1186/s12865-020-00352-1
|View full text |Cite|
|
Sign up to set email alerts
|

Thalidomide with blockade of co-stimulatory molecules prolongs the survival of alloantigen-primed mice with cardiac allografts

Abstract: Background: Miscellaneous memory cell populations that exist before organ transplantation are crucial barriers to transplantation. In the present study, we used a skin-primed heart transplantation model in mouse to evaluate the abilities of Thalidomide (TD), alone or in combination with co-stimulatory blockade, using monoclonal antibodies (mAbs) against memory T cells and alloantibodies to prolong the second cardiac survival. Results: In the skin-primed heart transplantation model, TD combined with mAbs signif… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 56 publications
0
2
0
Order By: Relevance
“…Following publication of the original article [ 1 ], the author noticed an error in the funding number available in the Funding section. The funding number of the National Natural Science Foundation of China was incorrectly given as 81771271 and should have been 81771721.…”
Section: Correction: Bmc Immunol (2020) 21:19 101186/s12865-020-00352-1mentioning
confidence: 99%
“…Following publication of the original article [ 1 ], the author noticed an error in the funding number available in the Funding section. The funding number of the National Natural Science Foundation of China was incorrectly given as 81771271 and should have been 81771721.…”
Section: Correction: Bmc Immunol (2020) 21:19 101186/s12865-020-00352-1mentioning
confidence: 99%
“…Mouse heterotopic heart transplantation was performed as previously described (18)(19)(20). BALB/c mouse hearts were transplanted into the necks of C57BL/6 mice.…”
Section: Heterotopic Cardiac Transplantationmentioning
confidence: 99%